Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 2

Results: 11

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 197, doi. 10.1007/s11523-021-00792-8

By:

Gassenmaier, Maximilian;
Lenders, Max M.;
Forschner, Andrea;
Leiter, Ulrike;
Weide, Benjamin;
Garbe, Claus;
Eigentler, Thomas K.;
Wagner, Nikolaus B.

Publication type:

Article

Is Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Superior Even to Lenvatinib? A Matching-Adjusted Indirect Comparison.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 249, doi. 10.1007/s11523-021-00803-8

By:

Casadei-Gardini, Andrea;
Tada, Toshifumi;
Shimose, Shigeo;
Kumada, Takashi;
Niizeki, Takashi;
Cascinu, Stefano;
Cucchetti, Alessandro

Publication type:

Article

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 215, doi. 10.1007/s11523-021-00798-2

By:

Wei, Jiacong;
Meng, Pei;
Terpstra, Miente Martijn;
van Rijk, Anke;
Tamminga, Menno;
Scherpen, Frank;
ter Elst, Arja;
Alimohamed, Mohamed Z.;
Johansson, Lennart F.;
Stigt, Jos;
Gijtenbeek, Rolof P. G.;
van Putten, John;
Hiltermann, T. Jeroen N.;
Groen, Harry J. M.;
Kok, Klaas;
van der Wekken, Anthonie J.;
van den Berg, Anke

Publication type:

Article

Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 165, doi. 10.1007/s11523-021-00794-6

By:

Cheng, Ying;
He, Yong;
Li, Wei;
Zhang, He-long;
Zhou, Qing;
Wang, Buhai;
Liu, Chunling;
Walding, Andrew;
Saggese, Matilde;
Huang, Xiangning;
Fan, Minhao;
Wang, Jia;
Ramalingam, Suresh S.

Publication type:

Article

BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 227, doi. 10.1007/s11523-021-00793-7

By:

Wong, Vanessa;
Lee, Margaret;
Wong, Rachel;
Tie, Jeanne;
Shapiro, Jeremy;
Desai, Jayesh;
Nott, Louise;
Steel, Simone;
Burge, Matthew;
Ma, Brigette;
Khattak, Adnan;
Hong, Wei;
Gibbs, Peter

Publication type:

Article

Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 207, doi. 10.1007/s11523-021-00791-9

By:

Chiang, Chi-Lu;
Lee, Cheng-Chia;
Huang, Hsu-Ching;
Wu, Chia-Hung;
Yeh, Yi-Chen;
Shen, Chia-I;
Luo, Yung-Hung;
Shiao, Tsu-Hui;
Chang, Han Jhih;
Huang, Yu-Ting;
Chen, Yuh-Min;
Chou, Teh-Ying;
Chiu, Chao-Hua

Publication type:

Article

Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 237, doi. 10.1007/s11523-021-00790-w

By:

Kono, Yoshiyasu;
Choda, Yasuhiro;
Nakagawa, Masahiro;
Miyahara, Koji;
Ishida, Michihiro;
Kubota, Tetsushi;
Seo, Keiji;
Hirata, Tetsu;
Obayashi, Yuka;
Gotoda, Tatsuhiro;
Moritou, Yuki;
Okikawa, Yoshiko;
Iwamoto, Yasuo;
Okada, Hiroyuki

Publication type:

Article

A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 177, doi. 10.1007/s11523-020-00789-9

By:

Zhang, Jian;
Yang, Nong;
Ji, Dongmei;
Shen, Weina;
Li, Wenhua;
Han, Rubing;
Wang, Ning;
Tao, Haoxun;
Chapman, Sonya C.;
Sykes, Amanda K.;
Zhang, Wanli;
Hu, Xichun

Publication type:

Article

Vaccine Therapies for Cancer: Then and Now.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 121, doi. 10.1007/s11523-020-00788-w

By:

Morse, Michael A.;
Gwin III, William R.;
Mitchell, Duane A.

Publication type:

Article

The Evolving Landscape of Checkpoint Inhibitor Combination Therapy in the Treatment of Advanced Hepatocellular Carcinoma.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 153, doi. 10.1007/s11523-020-00787-x

By:

Liu, Lin;
Qin, Shukui;
Zhang, Yu

Publication type:

Article

Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial Carcinoma.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 189, doi. 10.1007/s11523-020-00786-y

By:

Fukuokaya, Wataru;
Kimura, Takahiro;
Yanagisawa, Takafumi;
Kimura, Shoji;
Tsuzuki, Shunsuke;
Koike, Yuhei;
Iwamoto, Yuya;
Enei, Yuki;
Tanaka, Masatoshi;
Urabe, Fumihiko;
Onuma, Hajime;
Honda, Mariko;
Miki, Jun;
Oyama, Yu;
Abe, Hirokazu;
Egawa, Shin

Publication type:

Article